Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Article in English | MEDLINE | ID: mdl-38740579

ABSTRACT

PURPOSE: Common respiratory infections were significantly reduced during the COVID-19 pandemic due to general protective and hygiene measures. The gradual withdrawal of these non-pharmaceutical interventions (NPI) was associated with a notable increase in these infections, particularly in pediatric and adult otorhinolaryngology. The aim of this retrospective monocentric study was to evaluate the impact of NPI during the COVID-19 pandemic on the incidence and severity of acute mastoiditis (AM). METHODS: Pre-pandemic clinical data of AM cases from 2011 to 2019 were compared with infection counts from January 2020 to June 2023 for seasonal periodicity, age-specific differences, pathogens, and complication rates in a German third-level hospital. RESULTS: Out of 196 patients with AM 133 were children, the majority between 1 and 5 years of age. Complications of AM, such as meningitis, brain abscess, and sinus vein thrombosis, were more common in adults (87%) than in children (17%). Morbidity and mortality rates were similar before, during and after the pandemic. Pneumococci were the most common pathogen in both age groups, with a post-pandemic cumulation of Streptococcus pyogenes infections in children. While pre-pandemic cases clustered in spring, seasonality was absent in all age groups during the main phase of the pandemic. The cessation of NPI caused a steep rise in AM cases in both age groups starting from December 2022. CONCLUSION: NPI during the COVID-19 pandemic reduced the incidence of AM. Their reversal led to a substantial increase in the incidence of AM during the post-pandemic period, which may be due to a general increase in viral respiratory infections and an insufficiently trained immune system.

2.
Microorganisms ; 9(3)2021 Mar 15.
Article in English | MEDLINE | ID: mdl-33803988

ABSTRACT

To prevent the emergence of zoonotic infectious diseases and reduce their epidemic potential, we need to understand their origins in nature. Bats in the order Chiroptera are widely distributed worldwide and are natural reservoirs of prominent zoonotic viruses, including Nipah virus, Marburg virus, and possibly SARS-CoV-2. In this study, we applied unbiased metagenomic and metatranscriptomic approaches to decipher the virosphere of frugivorous and insectivorous bat species captured in Guéckédou, Guinea, the epicenter of the West African Ebola virus disease epidemic in 2013-2016. Our study provides a snapshot of the viral diversity present in these bat species, with several novel viruses reported for the first time in bats, as well as some bat viruses closely related to known human or animal pathogens. In addition, analysis of Mops condylurus genomic DNA samples revealed the presence of an Ebola virus nucleoprotein (NP)-derived pseudogene inserted in its genome. These findings provide insight into the evolutionary traits of several virus families in bats and add evidence that nonretroviral integrated RNA viruses (NIRVs) derived from filoviruses may be common in bat genomes.

3.
Gesundheitswesen ; 83(3): 231-234, 2021 Mar.
Article in German | MEDLINE | ID: mdl-33720386

ABSTRACT

Aerosols are currently seen as one of the main transmission routes for SARS-CoV-2, but a comprehensive understanding of the processes and appropriate action/adaptation of protection concepts requires the exchange of information across interdisciplinary boundaries. Against this background, the Baden-Württemberg state government launched in October 2020 a multidisciplinary "Expert Group Aerosols" comprising engineers, natural scientists and medical professionals. In its statement, the group has compiled the current state of knowledge in all relevant disciplines in the context of airborne SARS-CoV-2 infection. In addition to the well-known hygiene and social distancing rules, the importance of the correct use of effective masks is emphasized. Furthermore, the necessity for dynamic and correct ventilation is pointed out and illustrated with ventilation intervals and periods for different scenarios as examples. The effectiveness of stationary or mobile cabin air filters as an important component in the protection concept is discussed. The first opinion of the expert group makes it clear that the existing hygiene and social distancing rules offer the best possible protection against SARS-CoV-2 infection only when correctly applied in combination.


Subject(s)
COVID-19 , SARS-CoV-2 , Aerosols , Germany , Humans , Masks
4.
Infect Genet Evol ; 88: 104704, 2021 03.
Article in English | MEDLINE | ID: mdl-33418146

ABSTRACT

Different arthropod species are vectors of a wide array of arboviruses (arthropod-borne viruses) and have likely been central to viral evolution. To better understand the extent of arthropod-borne pathogens, as well as their origin and evolutionary history, it is crucial to uncover the full range of microbial agents, including viruses associated with arthropods. In this study, a collection of ticks obtained in 2016 directly from mammal and bird hosts from several rural and natural sites of Danube Delta was subjected to transcriptome sequencing and amplification assays. Vector surveillance revealed the presence of a novel orthonairovirus species, designated Sulina virus, in Ixodes ricinus ticks. Phylogenetic clustering of each viral protein consistently placed the new virus in the Orthonairovirus genus as a new genogroup closely related to Tamdy orthonairovirus, a genogroup comprising both pathogenic and tick-associated orthonairoviruses. The serological testing of engorged ticks and blood of infected hosts, along with the inoculation of vertebrate cells and mice found no specific antibodies or viral replication, suggesting that Sulina virus is an orthonairovirus associated with the virome of Ixodes ricinus. Finally, the characterization of a novel orthonairovirus identified using high throughput sequencing will advance our knowledge of interactions between viruses and tick vectors, expanding our perspective on fundamental questions regarding orthonairovirus evolution, diversity, ecology and potential of emergence as pathogens.


Subject(s)
Arthropod Vectors/virology , Ixodes/virology , Viruses/classification , Viruses/genetics , Viruses/metabolism , A549 Cells , Animals , Antibodies, Viral , Birds , Cattle , Cell Line , Chlorocebus aethiops , Dogs , Genome, Viral , High-Throughput Nucleotide Sequencing , Host Microbial Interactions , Humans , Madin Darby Canine Kidney Cells , Mice , Mice, Inbred C57BL , Nucleoproteins/genetics , Nucleoproteins/metabolism , Phylogeny , Serologic Tests , Tick-Borne Diseases/virology , Vero Cells , Viral Proteins/genetics , Viral Proteins/metabolism , Virus Diseases/virology , Viruses/immunology
5.
Viruses ; 12(2)2020 02 21.
Article in English | MEDLINE | ID: mdl-32098186

ABSTRACT

The discovery and characterization of novel arthropod-borne viruses provide valuable information on their genetic diversity, ecology, evolution and potential to threaten animal or public health. Arbovirus surveillance is not conducted regularly in Romania, being particularly very scarce in the remote and diverse areas like the Danube Delta. Here we describe the detection and genetic characterization of a novel orbivirus (Reoviridae: Orbivirus) designated as Letea virus, which was found in grass snakes (Natrix natrix) during a metagenomic and metatranscriptomic survey conducted between 2014 and 2017. This virus is the first orbivirus discovered in reptiles. Phylogenetic analyses placed Letea virus as a highly divergent species in the Culicoides-/sand fly-borne orbivirus clade. Gene reassortment and intragenic recombination were detected in the majority of the nine Letea virus strains obtained, implying that these mechanisms play important roles in the evolution and diversification of the virus. However, the screening of arthropods, including Culicoides biting midges collected within the same surveillance program, tested negative for Letea virus infection and could not confirm the arthropod vector of the virus. The study provided complete genome sequences for nine Letea virus strains and new information about orbivirus diversity, host range, ecology and evolution. The phylogenetic associations warrant further screening of arthropods, as well as sustained surveillance efforts for elucidation of Letea virus natural cycle and possible implications for animal and human health.


Subject(s)
Colubridae/virology , Genome, Viral , Genomics , Orbivirus/classification , Phylogeny , Reassortant Viruses/genetics , Animals , Arboviruses/genetics , Genetic Variation , Host Specificity , Orbivirus/isolation & purification , Psychodidae/virology , Reassortant Viruses/classification , Recombination, Genetic , Romania , Sequence Analysis, DNA , Whole Genome Sequencing
6.
Shock ; 52(4): e45-e51, 2019 10.
Article in English | MEDLINE | ID: mdl-30289852

ABSTRACT

Dysfunction of the gut-blood barrier plays an important role in many diseases, such as inflammatory bowel disease, hemorrhagic shock (HS), or burn injury. However, little is known about gut barrier dysfunction after hemodynamically instable polytrauma (PT). Therefore, we aimed to evaluate the effects of PT and HS on remote intestinal damage and barrier dysfunction, especially regarding the role of zonula occludens protein 1 (ZO-1) as an important tight junction protein.Male C57BL/6 mice were subjected to either PT (thorax trauma, closed head injury, soft tissue injury, and distal femoral fracture), 60 min of pressure-controlled HS (30 ±â€Š5 mmHg), or PT+HS, or sham procedures.Animals of all trauma groups showed an increase in abdominal girth and dilation of the intestine during the experimental period, which was largest in the PT+HS group. Increased blood-tissue permeability to albumin (assessed by Evans blue dye) was found in the HS group. Experimental groups showed a slight increase in plasma concentration of intestinal fatty acid binding protein and some intestinal damage was histologically detectable. Of note, PT+HS animals revealed significantly reduced expression of ZO-1 in intestinal epithelial cells. In an in-vitro model, stimulation of human colon epithelial cells with peptidoglycan, but not with lipopolysaccharide, resulted in elevated secretion of pro-inflammatory cytokines, reflecting inflammatory activity of the intestinal epithelium.Taken together, PT and HS lead to increased permeability of the gut-blood barrier. Bacterial components may lead to production of inflammatory and chemotactic mediators by gut epithelial cells, underlining the role of the gut as an immunologically active organ.


Subject(s)
Intestinal Diseases , Intestines , Multiple Trauma , Shock, Hemorrhagic , Animals , Disease Models, Animal , Intestinal Diseases/metabolism , Intestinal Diseases/pathology , Intestines/injuries , Intestines/pathology , Mice , Multiple Trauma/metabolism , Multiple Trauma/pathology , Permeability , Shock, Hemorrhagic/metabolism , Shock, Hemorrhagic/pathology
7.
J Antimicrob Chemother ; 73(7): 1812-1814, 2018 07 01.
Article in English | MEDLINE | ID: mdl-29590370

ABSTRACT

Background: Antimicrobial resistance due to carbapenemase expression poses a worldwide threat in healthcare. Inter-genus exchange of genetic information is of utmost importance in this context. Objectives: Here, to the best of our knowledge, we describe the first detection and characterization of a KPC-2-producing Pseudomonas aeruginosa in Germany. Methods: Characterization of the isolate was performed using MALDI-TOF MS, automated microdilution and MLST. Carbapenemase detection was performed using phenotypic and genotypic assays. The blaKPC-2-carrying plasmid was transformed into Escherichia coli NEB® 10-beta. The purified plasmid DNA was sequenced using the Illumina technique. Results: The isolate expressed ST235 and was resistant to carbapenems. Antimicrobial susceptibility testing revealed colistin to be the only antimicrobial agent active in vitro. The blaKPC-2 gene was located on a replicon type lncHI1 plasmid as part of Tn4401. Conclusions: The first detection (to the best of our knowledge) of plasmid-encoded KPC-2 in P. aeruginosa in Germany may point to a currently underestimated spread of carbapenemases among clinically relevant Gram-negative bacteria. Here, to the best of our knowledge, we also provide the first report of blaKPC-2 associated with the IncHI1 plasmid.


Subject(s)
Anti-Bacterial Agents/pharmacology , Carbapenems/pharmacology , Drug Resistance, Multiple, Bacterial/genetics , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/genetics , beta-Lactamases/genetics , DNA, Bacterial/genetics , DNA, Bacterial/isolation & purification , Female , Genotype , Germany , High-Throughput Nucleotide Sequencing , Humans , Microbial Sensitivity Tests , Multilocus Sequence Typing , Plasmids/genetics , Pseudomonas Infections/microbiology , Pseudomonas Infections/urine , Pseudomonas aeruginosa/enzymology , Sequence Analysis, DNA
8.
J Infect ; 72(5): 554-63, 2016 May.
Article in English | MEDLINE | ID: mdl-26940505

ABSTRACT

OBJECTIVES: We aimed to identify clinical characteristics and to assess effectiveness of different initial antibiotic regimens in adult patients with community-acquired pneumonia (CAP) caused by Haemophilus influenzae. METHODS: Characteristics were compared between patients with H. influenzae monoinfection versus CAP of other and unknown aetiology enrolled by the German prospective cohort study CAPNETZ. Impact of initial antibiotic treatment on "early clinical response" according to FDA criteria and overall clinical cure were analysed. RESULTS: H. influenzae was found in 176 out of 2790 patients with pathogen detection (6.3%). Characteristics significantly associated with a H. influenzae CAP (p < 0.017) included purulent sputum, prior pneumococcal vaccination and respiratory co-morbidities. Early clinical response rates on day 4 did not differ between patients receiving any mono- versus combination therapy (85.9% versus 88%), but were numerically higher for regimens including any fluoroquinolone (96.7%) and lower under macrolide monotherapy (70%). Initial CURB-65 score and chronic liver disease were identified as negative predictors for "early clinical response". At day 14, overall clinical cure was 91.9%. CONCLUSIONS: H. influenzae was a common CAP pathogen, particularly in patients with previous pneumococcal vaccination and respiratory co-morbidities. Severity of illness and chronic liver disease were associated with a lower rate of "early clinical response".


Subject(s)
Anti-Bacterial Agents/therapeutic use , Community-Acquired Infections/epidemiology , Haemophilus Infections/epidemiology , Haemophilus influenzae/isolation & purification , Pneumonia, Bacterial/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Community-Acquired Infections/drug therapy , Community-Acquired Infections/microbiology , Community-Acquired Infections/pathology , Female , Germany/epidemiology , Haemophilus Infections/drug therapy , Haemophilus Infections/microbiology , Haemophilus Infections/pathology , Humans , Male , Middle Aged , Pneumonia, Bacterial/drug therapy , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/pathology , Prospective Studies , Treatment Outcome , Young Adult
9.
Int J Med Microbiol ; 306(2): 109-14, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26868659

ABSTRACT

An explosive outbreak of Legionnaires' disease with 64 reported cases occurred in Ulm/Neu-Ulm in the South of Germany in December 2009/January 2010 caused by Legionella (L.) pneumophila serogroup 1, monoclonal (mAb) subtype Knoxville, sequence type (ST) 62. Here we present the clinical microbiological results from 51 patients who were diagnosed at the University hospital of Ulm, the results of the environmental investigations and of molecular typing of patients and environmental strains. All 50 patients from whom urine specimens were available were positive for L. pneumophila antigen when an enzyme-linked immunosorbent assay (EIA) was used following concentration of those urine samples that tested initially negative. The sensitivity of the BinaxNow rapid immunographic assay (ICA), after 15 min reading and after 60 min reading were 70% and 84%, respectively. Direct typing confirmed the monoclonal subtype Knoxville in 5 out of 8 concentrated urine samples. Real time PCR testing of respiratory tract specimens for L. pneumophila was positive in 15 out of 25 (60%) patients. Direct nested sequence based typing (nSBT) in some of these samples allowed partial confirmation of ST62. L. pneumophila serogroup 1, monoclonal subtype Knoxville ST62, defined as the epidemic strain was isolated from 8 out of 31 outbreak patients (26%) and from one cooling tower confirming it as the most likely source of the outbreak. While rapid detection of Legionella antigenuria was crucial for the recognition and management of the outbreak, culture and molecular typing of the strains from patients and environmental specimens was the clue for the rapid identification of the source of infection.


Subject(s)
Disease Outbreaks , Legionella/classification , Legionellosis/microbiology , Adult , Aged , Aged, 80 and over , Antigens, Bacterial/urine , DNA, Bacterial/analysis , Environmental Microbiology , Female , Germany/epidemiology , Humans , Legionella/genetics , Legionella/immunology , Legionellosis/diagnosis , Legionellosis/epidemiology , Male , Middle Aged , Real-Time Polymerase Chain Reaction , Respiratory System/microbiology , Serotyping
11.
BMC Infect Dis ; 14: 37, 2014 Jan 21.
Article in English | MEDLINE | ID: mdl-24447780

ABSTRACT

BACKGROUND: Reusable surface disinfectant tissue dispensers are used in hospitals in many countries because they allow immediate access to pre-soaked tissues for targeted surface decontamination. On the other hand disinfectant solutions with some active ingredients may get contaminated and cause outbreaks. We determined the frequency of contaminated surface disinfectant solutions in reusable dispensers and the ability of isolates to multiply in different formulations. METHODS: Reusable tissue dispensers with different surface disinfectants were randomly collected from healthcare facilities. Solutions were investigated for bacterial contamination. The efficacy of two surface disinfectants was determined in suspension tests against two isolated species directly from a contaminated solution or after 5 passages without selection pressure in triplicate. Freshly prepared use solutions were contaminated to determine survival of isolates. RESULTS: 66 dispensers containing disinfectant solutions with surface-active ingredients were collected in 15 healthcare facilities. 28 dispensers from nine healthcare facilities were contaminated with approximately 107 cells per mL of Achromobacter species 3 (9 hospitals), Achromobacter xylosoxidans or Serratia marcescens (1 hospital each). In none of the hospitals dispenser processing had been adequately performed. Isolates regained susceptibility to the disinfectants after five passages without selection pressure but were still able to multiply in different formulations from different manufacturers at room temperature within 7 days. CONCLUSIONS: Neglecting adequate processing of surface disinfectant dispensers has contributed to frequent and heavy contamination of use-solutions based on surface active ingredients. Tissue dispenser processing should be taken seriously in clinical practice.


Subject(s)
Disinfectants/administration & dosage , Disinfection/instrumentation , Drug Contamination/statistics & numerical data , Achromobacter/isolation & purification , Disinfection/standards , Serratia marcescens/isolation & purification
12.
Dtsch Arztebl Int ; 110(38): 634-40, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24133545

ABSTRACT

BACKGROUND: Nosocomial pneumonia is among the most common types of infection in hospitalized patients. The increasing prevalence of multi-drug resistant organisms (MDROs) in recent years points to the need for an up-to-date clinical guideline. METHODS: An interdisciplinary S3 guideline was created on the basis of a systematic literature review in the PubMed and Cochrane Library databases, with assessment and grading of the evidence according to the GRADE system. RESULTS: 9097 abstracts and 808 articles were screened in full text, and 22 recommendations were issued. It is recommended that any antimicrobial treatment should be preceded by a microbiological diagnostic evaluation with cultures of blood and respiratory samples. The diagnosis of nosocomial pneumonia should be suspected in any patient with a new or worsened pulmonary infiltrate who meets any two of the following three criteria: leucocyte count above 10,000 or below 4000/µL, temperature above 38.3°C, and/or the presence of purulent respiratory secretions. The initially calculated antimicrobial treatment should be begun without delay; it should be oriented to the locally prevailing resistance pattern, and its intensity should be a function of the risk of infection with MDROs. The initial treatment should be combination therapy if there is a high risk of MDRO infection and/or if the patient is in septic shock. In the new guideline, emphasis is laid on a strict de-escalation concept. In particular, antimicrobial treatment usually should not be continued for longer than eight days. CONCLUSION: The new guideline's recommendations are intended to encourage rational use of antibiotics, so that antimicrobial treatment will be highly effective while the unnecessary selection of multi-drug-resistant organisms will be avoided.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Cross Infection/epidemiology , Cross Infection/prevention & control , Pneumonia, Bacterial/epidemiology , Pneumonia, Bacterial/prevention & control , Practice Guidelines as Topic , Pulmonary Medicine/standards , Adult , Cross Infection/diagnosis , Female , Germany/epidemiology , Humans , Male , Pneumonia, Bacterial/diagnosis , Prevalence , Risk Factors
14.
Int J Med Microbiol ; 301(1): 53-7, 2011 Jan.
Article in English | MEDLINE | ID: mdl-20692869

ABSTRACT

We investigated the usage of fluoroquinolones and the prevalence of fluoroquinolone resistant pneumococci and their precursors (first step mutants and efflux expressing isolates) in patients with community-acquired pneumonia, who were enroled into the German CAPNETZ surveillance study from 2002 to 2006 before the introduction of the pneumococcal conjugate vaccine (n=5780). Thirty-eight percent of all outpatients received fluoroquinolones. Moxifloxacin accounted for 70%, levofloxacin for 19% and ciprofloxacin for 9% of all fluoroquinolone prescriptions. One hundred and sixty-three pneumococcal isolates from 556 patients with pneumococcal pneumonia were analyzed for fluoroquinolone resistance, efflux phenotype, prevalence of mutations within the quinolone-resistance determining regions and clonality. None of the isolates exhibited fluoroquinolone resistance, 1.2% of the isolates contained a first step mutation and 6.7% exhibited an efflux phenotype. There was no clonal relationship among these strains at increased risk for fluoroquinolone resistance. The absence of fluoroquinolone resistance in the context of high fluoroquinolone usage might be explained by the high proportion of third-generation fluoroquinolones with enhanced activity against pneumococci.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Community-Acquired Infections/microbiology , Drug Resistance, Bacterial , Drug Utilization/statistics & numerical data , Fluoroquinolones/therapeutic use , Pneumonia, Pneumococcal/microbiology , Streptococcus pneumoniae/drug effects , Adult , Aged , Aged, 80 and over , Community-Acquired Infections/epidemiology , Female , Germany/epidemiology , Humans , Male , Middle Aged , Pneumonia, Pneumococcal/epidemiology , Prevalence , Streptococcus pneumoniae/isolation & purification
15.
Respir Res ; 10: 65, 2009 Jul 12.
Article in English | MEDLINE | ID: mdl-19594893

ABSTRACT

BACKGROUND: Aim of this study was to evaluate the correlation of inflammatory markers procalcitonin (PCT), C-reactive protein (CRP) and leukocyte count (WBC) with microbiological etiology of CAP. METHODS: We enrolled 1337 patients (62 +/- 18 y, 45% f) with proven CAP. Extensive microbiological workup was performed. In all patients PCT, CRP, WBC and CRB-65 score were determined. Patients were classified according to microbial diagnosis and CRB-65 score. RESULTS: In patients with typical bacterial CAP, levels of PCT, CRP and WBC were significantly higher compared to CAP of atypical or viral etiology. There were no significant differences in PCT, CRP and WBC in patients with atypical or viral etiology of CAP. In contrast to CRP and WBC, PCT markedly increased with severity of CAP as measured by CRB-65 score (p < 0.0001). In ROC analysis for discrimination of patients with CRB-65 scores > 1, AUC for PCT was 0.69 (95% CI 0.66 to 0.71), which was higher compared to CRP and WBC (p < 0.0001). CRB-65, PCT, CRP and WBC were higher (p < 0.0001) in hospitalised patients in comparison to outpatients. CONCLUSION: PCT, CRP and WBC are highest in typical bacterial etiology in CAP but do not allow individual prediction of etiology. In contrast to CRP and WBC, PCT is useful in severity assessment of CAP.


Subject(s)
Community-Acquired Infections/etiology , Community-Acquired Infections/pathology , Inflammation/etiology , Inflammation/pathology , Pneumonia/etiology , Pneumonia/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Biomarkers , C-Reactive Protein/metabolism , Calcitonin/blood , Calcitonin Gene-Related Peptide , Community-Acquired Infections/diagnosis , Female , Germany , Humans , Inflammation/diagnosis , Leukocyte Count , Male , Middle Aged , Pneumonia/diagnosis , Pneumonia, Bacterial/etiology , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/pathology , Pneumonia, Viral/etiology , Pneumonia, Viral/pathology , Pneumonia, Viral/virology , Protein Precursors/blood , ROC Curve , Young Adult
16.
BMC Infect Dis ; 9: 62, 2009 May 13.
Article in English | MEDLINE | ID: mdl-19439072

ABSTRACT

BACKGROUND: Currently, broad empiric antimicrobial treatment including atypical coverage is recommended for patients with mild to moderate community-acquired pneumonia (CAP). Therefore, the relative impact of each atypical pathogen, particularly Mycoplasma pneumoniae deserves renewed attention. METHODS: Based on prospective data from 4532 patients with CAP included in the German CAP-Competence Network (CAPNETZ), we studied the incidence, clinical characteristics, and outcome of patients with Mycoplasma pneumoniae pneumonia (MPP). The diagnosis of MPP was based on a positive PCR from respiratory samples and/or a positive IgM-titer from an acute phase serum sample. RESULTS: 307 patients (6.8%) had definite MPP (148 with positive PCR, 204 with positive IgM, 46 with positive PCR and IgM). Compared to patients with other definite and unknown etiologies, patients with MPP were significantly younger (41 +/- 16 versus 62 +/- 17 and 61 +/- 18 years), had fewer co-morbidities, presented with a less severe disease, showed a lower inflammatory response in terms of leukocyte counts (median 8850 versus 13200 and 11000 microL) and CRP values (60 versus 173 and 73 mg/L), and had better outcomes, including a shorter length of hospitalization (9 +/- 5 versus 14 +/- 11 and 12 +/- 9 days), fewer patients requiring mechanical ventilation (0.3 versus 4.5 and 2.1%), and a minimal mortality (0.7 versus 8.7 and 6.5%). CONCLUSION: In this large series of patients with definite MPP according to very strict criteria, MPP appears as a condition with a high incidence, quite specific clinical presentation, and a largely benign course. In view of a widely favorable clinical outcome, recent recommendations including regular coverage of atypical pathogens in patients with mild to moderate CAP might be reconsidered for patients in Germany as well as in other countries with comparable epidemiological settings.


Subject(s)
Community-Acquired Infections/epidemiology , Mycoplasma pneumoniae/isolation & purification , Pneumonia, Mycoplasma/epidemiology , Adult , Aged , Analysis of Variance , Chi-Square Distribution , Community-Acquired Infections/diagnosis , Community-Acquired Infections/microbiology , Female , Germany/epidemiology , Humans , Immunoenzyme Techniques , Incidence , Male , Middle Aged , Mycoplasma pneumoniae/genetics , Pneumonia, Mycoplasma/diagnosis , Pneumonia, Mycoplasma/microbiology , Polymerase Chain Reaction , Prospective Studies , Public Health
17.
J Hosp Infect ; 70 Suppl 1: 58-9, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18994684

ABSTRACT

The results of an anonymised and voluntary survey asking for characteristics of an ideal hand disinfectant are presented. Participants were 475 healthcare workers from a German University Hospital.


Subject(s)
Anti-Infective Agents, Local , Attitude of Health Personnel , Hand Disinfection , Consumer Behavior , Data Collection , Hospitals, University , Humans
18.
Clin Infect Dis ; 46(9): 1356-64, 2008 May 01.
Article in English | MEDLINE | ID: mdl-18419436

ABSTRACT

BACKGROUND: The Competence Network for Community Acquired Pneumonia (CAPNETZ) offers a unique opportunity to study the epidemiology of legionellosis throughout Germany, applying sophisticated diagnostic tools. METHODS: The incidence, clinical characteristics, and outcome of Legionella pneumonia in 2503 adult patients with community-acquired pneumonia, participating in the German Multicenter Study of the CAPNETZ, were studied. RESULTS: Legionella pneumonia was diagnosed in 94 patients (3.8%), thus identifying Legionella species as one of the most common pathogens to cause community-acquired pneumonia. It was equally common among ambulatory and hospitalized patients (3.7% and 3.8%, respectively). The predominant species causing community-acquired pneumonia was Legionella pneumophila; however, 10% of cases were caused by other species not detectable by the urinary antigen test. Patients whose disease was diagnosed by urinary antigen testing experienced a more severe clinical course. Compared with hospitalized patients, ambulatory patients with Legionella pneumonia showed an equal sex distribution, were younger, had fewer comorbidities, fewer cases of discordant initial antimicrobial treatment, and a milder clinical course without fatalities. Thirty percent of patients with Legionella pneumonia received discordant initial antimicrobial treatment without increased mortality. CONCLUSIONS: Legionella is a leading cause of community-acquired pneumonia in Germany. It needs to be considered equally in hospitalized and ambulatory patients. A positive result of a urine antigen test is associated with a more severe clinical course and leads to a potentially relevant underrecognition of species other than L. pneumophila. Legionella pneumonia in outpatients differs significantly from that in hospitalized patients in terms of clinical presentation and outcome. There was an unacceptably high rate of discordant initial antimicrobial treatment.


Subject(s)
Community-Acquired Infections/diagnosis , Legionella/isolation & purification , Legionellosis/diagnosis , Pneumonia/diagnosis , Adult , Aged , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Female , Germany/epidemiology , Humans , Incidence , Legionella/genetics , Legionellosis/epidemiology , Male , Middle Aged , Pneumonia/epidemiology , RNA, Ribosomal, 16S/genetics
19.
Intensive Care Med ; 33(12): 2069-78, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17938883

ABSTRACT

OBJECTIVE: Community acquired pneumonia (CAP) is the most important clinical infection. Therefore, the CAP competence network CAPNETZ was instituted in Germany. The aim of this substudy was to evaluate the value of pro-atrial natriuretic peptide (MR-proANP) and pro-vasopressin (CT-proAVP) for severity assessment and outcome prediction in CAP. DESIGN: Prospective observational study. SETTING: German CAP competence network CAPNETZ. METHODS: We enrolled 589 patients (age 61+/-18 years, 46% female) with proven CAP. MR-proANP, CT-proAVP, C-reactive protein (CRP), procalcitonin (PCT) and CRB-65 score were determined on admission. RESULTS: MR-proANP, CT-proAVP and PCT levels, but not CRP, increased with increasing severity of CAP, classified according to the CRB-65 score. In patients who died during 28-day follow-up, median MR-proANP and CT-proAVP levels (respectively 237.0 vs. 93.5 pmol/l and 44.2 vs. 12.4 pmol/l, each p<0.0001) were significantly higher than in survivors. In receiver operating characteristic (ROC) analysis for survival, the area under the curve (AUC) values for CT-proAVP (0.86, 95% CI 0.83-0.89) and MR-proANP (0.76, 95% CI 0.72-0.80) were similar to the AUC of CRB-65 (0.73, 95% CI 0.70-0.77). In multivariable Cox proportional-hazards regression analyses including MR-proANP/CT-proAVP, coexisting illnesses and CRB-65, increased MR-proANP and CT-proAVP concentrations were the strongest predictors of mortality. CONCLUSIONS: MR-proANP and CT-proAVP are useful new biomarkers for the risk stratification of CAP patients. They are significantly lower in CAP survivors and correlate with the severity of the disease measured by CRB-65 score.


Subject(s)
Atrial Natriuretic Factor/analysis , Community-Acquired Infections/physiopathology , Severity of Illness Index , Vasopressins/analysis , Adolescent , Adult , Aged , Aged, 80 and over , Area Under Curve , Atrial Natriuretic Factor/blood , Biomarkers/blood , C-Reactive Protein/analysis , Calcitonin/analysis , Calcitonin/blood , Calcitonin Gene-Related Peptide , Community-Acquired Infections/blood , Community-Acquired Infections/classification , Female , Germany , Glycopeptides/analysis , Glycopeptides/blood , Humans , Male , Middle Aged , Prognosis , Proportional Hazards Models , Prospective Studies , Protein Precursors/analysis , Protein Precursors/blood , Vasopressins/blood
20.
J Clin Epidemiol ; 60(11): 1149-55, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17938057

ABSTRACT

OBJECTIVE: In young children infections with resistant Escherichia coli (E. coli) can lead to life-threatening situations. Epidemiological data on the prevalence and major determinants of carriage of antibiotic resistant E. coli among children in the community setting are sparse. STUDY DESIGN AND SETTING: In a population-based study from Germany, stool samples were obtained from children aged 6 months to 4 years attending a pediatrician for a regular health screening (N=568) or an acute infection (N=316), as well as from their parents (N=1,594) and siblings (N=624). E. coli was cultured, and minimal inhibitory concentrations to various antibiotics were tested. We determined prevalences of E. coli resistance to commonly prescribed antibiotics and their association with potential risk factors. RESULTS: Prevalence of E. coli resistance was 16.6%, 8.7%, and 11.6% for ampicillin, cotrimoxazole, and doxycycline, respectively. Strong associations were found with antibiotic resistance among siblings (odds ratios [95% confidence intervals] for ampicillin, doxycycline, and cotrimoxazole resistance: 4.4 [1.8-10.8], 8.0 [3.0-21.2], and 10.8 [3.5-32.7], respectively). CONCLUSION: Resistance prevalences in this community-based study were much lower than those reported from the clinical sector. Household contacts seem to be the key factor for children;s colonization with resistant E. coli in the community setting.


Subject(s)
Escherichia coli Infections/epidemiology , Age Distribution , Ampicillin Resistance , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents/therapeutic use , Child, Preschool , Community-Acquired Infections/drug therapy , Community-Acquired Infections/epidemiology , Community-Acquired Infections/transmission , Doxycycline/therapeutic use , Drug Resistance, Bacterial , Drug Resistance, Multiple, Bacterial , Escherichia coli Infections/drug therapy , Escherichia coli Infections/transmission , Feces/microbiology , Female , Germany/epidemiology , Humans , Infant , Male , Parents , Patient Acceptance of Health Care , Prevalence , Risk Factors , Siblings , Socioeconomic Factors , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...